Source-linked briefing Science

Engineered Bacteria Zero In on Tumors to Trigger Immune Response

Engineered Bacteria Zero In on Tumors to Trigger Immune Response

Researchers at the University of Rhode Island report reengineering oncolytic bacteria to better target cancerous tumors and alert the immune system. The approach involves injecting bacteria into tumors to expose cancer cells to immune attack.

Original headline

Genetically reengineered bacteria targets cancerous tumors